Characteristics of some clinical and paraclinical features of patients with bronchial asthma in the post-COVID-19 period
DOI:
https://doi.org/10.52692/1857-0011.2024.3-80.27Keywords:
Bronchial asthma, post-COVID-19 period, clinical features, elderly patientsAbstract
The analysis of cases with bronchial asthma in the post-COVID-19 period highlights the frequency of respiratory, cardiovascular and neuropsychiatric symptoms, increased inflammatory biochemical markers, dysregulation of pulmonary respiratory function. Elderly patients with asthma in the post-COVID-19 period exhibit some peculiarities, such as high comorbidity, use of a large number of medications, individualized response to treatment, different perception of symptoms and a higher mortality rate. These aspects emphasize the need to maintain optimal asthma control and prevent exacerbations that can accelerate the progression to respiratory failure. Further research is needed to effectively address issues related to different asthma phenotypes, treatment intensity and degree of disease
References
Protocol clinic național (ediția VIII) PCN-371. Chișinău, 2023, 91 p.
Borobia A., Caracas A., Amalich F., et al. A cohort of patients with Covid-19 in major teaching hospital in Europe. J. Clin. Med., 2020; 9:1733.
Ciotti M., Ciccozzi M., Terrinoni A., et al. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci., 2020; 57:365-88.
Harapan H., Itoh N., Yufika A., Winardi W., et al. Coronavirus disease 2019 (COVID-19): A literature review. J. Infect. Public Health., 2020; 13:667-73.
Song W., Hui C.R., Hull M., et.al. Confronting COVID- 19-associated cough an the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir. Med., 2021; 9:5330544.
Assaf S., Stenberg H., Jesenak M. Asthma in the era of COVID-19. Medicină Respiratorie, 2023; 218:107373.
Kaszuba M., Madej N., Pilinski R., Sliwka A., et.al. Post-COVID-19 Symptoms in Adults with Asthma - Systematic Review., Biomedicines, 2023; 11:2268.
Chen C., Spencer R., Zimmermann L., Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review. MedRxiv. https://doi.org/10.1101/2921.1.11.15.2126637.
Sudre C., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat. Med., 2021; 27(4):626-63.
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet., 1998; 351:1225-32.
Howell D., Verma H., Ho K., et.al. Asthma and Covid-19: lessons leamed and questions that remain. Expert Rev. Respir. Med., 2021; 15:1377-1386.
Kamal B., Khalaf M. Ali. Impact of COVID-19 on asthma control in Kirkuk City: an analysis of post- pandemic trends. J. of Mtdicine and Life, 2024; 17.
Davies G., Alsallakh M., Sivakumaran S., et al. EAVE II Collaborators. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax., 2021; 76:867-73.
Shah S.A., Quint J.K., Nwaru B.I, Sheikh A. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax., 2021; 76:860-6; Erratum in: Thorax., 2023; 76:867-73.
Sunjaya A., Allida S., Di Tanna G., et al. Asthma and COVID-19 risk: a systematic review and meta- analysis. Eur. Respir. J., 2022; 59(3):2101209. doi:10.1183/13993003.01209-2021
Hui K., Ho J., Cheung M., et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature., 2022; 603 (7902):715-720.
Gaietto K., Bergum N., Rosser F., et al. Odds of COVID-19-associated asthma exacerbations in children higher during Omicron wave. Pediatr Pulmonol., 2023; 58(11):3179-3187. doi:10.1002/ppul.26642.
Zhu Z., Hasegawa K., Ma B., Fujiogi M, Camargo CA Jr, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID19. The Journal of Allergy and Clinical Immunology, 2020, Aug;146(2):3279.e4.
Adir Y., Humbert M., Saliba W. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence. J. Allergy Clin Immunol., 2021; 148(2):361-367.e13., doi:10.1016/J. JACI.2021.06.006.
Jackson D., Busse W., Bacharier L., et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J.Allergy Clin. Immunol., 2020; 146:203-6.e3.
Sajuthi S., De Ford P., Li Y., Jackson N., Montgomery M., Everman J., et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat. Commun., 2020; 11:5139.
Kimura H., Francisco D., Conway M., et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J. Allergy Clin. Immunol., 2020; 146:80-8.e8.
Peters M., Sajuthi S., Deford P., et al. COVID-19– related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. Am J. Respir. Crit. Care. Med., 2020; 202:83-90. Erratum in: Am J Respir Crit Care Med., 2020; 202:1744-6.
Chu K., Akl E., Duda S., et al. COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS- CoV-2 and COVID-19: a systematic review and meta- analysis. Lancet, 2020; 395:1973-87.
Bloom C.I. Covid-19 pandemic and asthma: What did we learn? Respirology, 2023; 28:603-614.
Hazan G., Fox C., Mok H., Haspel J. Age-dependent rebound in asthma exacerbations after COVID-19 lockdown. J. Allergy Clin. Immunol., Glob., 2022; 1:314-8.
Liqin W., Dinah F., Yuqing Z., et al. PosteAcute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Recordse Based Study.J. Allergy Clin. Immunol., 2023.
Einat S., Ophir B., Ben A., et al. Pulmonary Evaluation in Children with Post-COVID-19 Condition Respiratory Symptoms: A Prospective Cohort Study.
Melinte O., Robu D., Dobrin. M., și al. Assessment of Some Risk Factors and Biological Predictors in the Post COVID-19 Syndrome in Asthmatic Patients. J. Pers. Med., 2024; 14:21.
Butler M., O’Reilly A., Dunican E., et al. Prevalence of comorbid asthma in COVID-19 patients. J. Allergy Clin. Immunol., 2020; 146:334-5.
BeurnierA., Jutant, E., Jevnikar M., etal. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalization. Eur. Respir. J., 2020; Nov 5;56(5):2001875.
Nassoro D., Mujwahuzi L., Habakkuk Mwakyula I., et al. Asthma and COVID-19: Emphasis on Adequate Asthma Control. Canadian Respiratory Journal, 2021; 2021:9621572. htpps://doi. org/10.1155/2021/9621572.
Milanese M., Di Marco F., Corsico A.G., et al. ELSA Study Group. Asthma control in elderly asthmatics. An Italian observational study. Respir. Med., 2014; 108(8):1091-9. doi:10.1016/j.rmed.2014.05.016.
Авдеев С.Н., Гайнитдинова В.В., Позднякова А.А и др. Факторы риска неблагоприятных исходов у по- жилых пациентов с бронхиальной астмой и тяже- лой формой COVID-19 на госпитальном и раннем по- стгоспитальном этапах. Тер. арх., 2023; 95(1):57-65.
Khojasteh-Kaffash S., Parhizkar Roudsari P., Ghaffari Jolfayi A., Samieefar N., Rezaei N. Pediatric asthma exacerbation and COVID-19 pandemic: Impacts, challenges, and future considerations. Journal of Asthma, 2023; 61(2):81-91.
Keir E., James P., Buttery S., Parris W., et al. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ, Open Resp. Res., 2022; 9:e001056.
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
